Editorial: current challenges in predicting mortality in patients with cirrhosis and refractory ascites

Sara Mahgoub¹, Matthew J Armstrong^{1

2}, James W Ferguson^{1

2}

Affiliations

¹ Liver Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
² Institute of Immunology and Immunotherapy, National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK.

Editorial

Sara Mahgoub et al. Aliment Pharmacol Ther. 2020 Sep.

. 2020 Sep;52(5):885-886.

doi: 10.1111/apt.15982.

Sara Mahgoub¹, Matthew J Armstrong^{1

2}, James W Ferguson^{1

2}

¹ Liver Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
² Institute of Immunology and Immunotherapy, National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK.

No abstract available

Comment on

MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascites.
Jepsen P, Watson H, Macdonald S, Vilstrup H, Jalan R. Jepsen P, et al. Aliment Pharmacol Ther. 2020 Aug;52(3):492-499. doi: 10.1111/apt.15882. Epub 2020 Jun 23. Aliment Pharmacol Ther. 2020. PMID: 32573818

1. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864-871.
1. Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Liver Transpl. 2011;17:129-136.
1. Jepsen P, Watson H, Macdonald S, Vilstrup H, Jalan R. MELD remains the best predictor of mortality in outpatients with cirrhosis and severe. Aliment Pharmacol Ther. 2020;52:492-499. https://doi.org/10.1111/apt.15882
1. Mazumder NR, Atiemo K, Kappus M, et al. A comprehensive review of outcome predictors in low MELD patients. Transplantation. 2020;104:242-250.
1. Cullaro G, Verna EC, Lai JC. Association between renal function pattern and mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2019;17:2364-2370.